CYPRESS, Calif.--(BUSINESS WIRE)--Christie®, a global visual technologies company, announced today that it has acquired substantially all of the assets of Luminetx® Corporation, a medical biosciences technology company. The assets include Luminetx’ technology and intellectual property for the market leading vascular imaging system, VeinViewer®. VeinViewer is the first device to utilize patented technologies to locate subcutaneous veins and project a real-time image of their location onto the surface of the skin. Christie will create a new medical products business operating under Christie Medical Holdings, Inc. (“Christie Medical”).
